These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7748139)

  • 1. Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC.
    Besen G; Flores-Aguilar M; Assil KK; Kupperman BD; Gangan P; Pursley M; Munguia D; Vuong C; De Clercq E; Bergeron-Lynn G
    Arch Ophthalmol; 1995 May; 113(5):661-8. PubMed ID: 7748139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis.
    Kuppermann BD; Assil KK; Vuong C; Besen G; Wiley CA; De Clercq E; Bergeron-Lynn G; Connor JD; Pursley M; Munguia D; Freeman WR
    J Infect Dis; 1996 Jan; 173(1):18-23. PubMed ID: 8537656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
    Flores-Aguilar M; Huang JS; Wiley CA; De Clercq E; Vuong C; Bergeron-Lynn G; Chandler B; Munguia D; Freeman WR
    J Infect Dis; 1994 Mar; 169(3):642-7. PubMed ID: 8158041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
    Cundy KC; Lynch G; Shaw JP; Hitchcock MJ; Lee WA
    Curr Eye Res; 1996 May; 15(5):569-76. PubMed ID: 8670758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine.
    Dolnak DR; Munguia D; Wiley CA; De Clercq E; Bergeron-Lynn GL; Boscher C; Connor JD; Sherwood C; Capparelli E; Armani R
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1557-63. PubMed ID: 1559752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
    Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Taskintuna I; Rahhal FM; Arevalo JF; Munguia D; Banker AS; De Clercq E; Freeman WR
    Ophthalmology; 1997 Jun; 104(6):1049-57. PubMed ID: 9186448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of herpes retinitis in an animal model with a sustained delivery antiviral drug, liposomal 1-O-octadecyl-SN-glycerol-3-phosphonoformate.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Ozerdem U; Bergeron-Lynn G; Mach-Hofacre B; Mueller AJ; Severson GM; Freeman WR
    Retina; 1999; 19(4):325-31. PubMed ID: 10458299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of partial retinal destruction and gliosis on the intravitreal pharmacokinetics of HPMPC.
    Kim JW; el-Haig W; Capparelli EV; Besen G; Connor JD; Freeman WR
    Retina; 1995; 15(6):513-7. PubMed ID: 8747447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPMPC therapy of MCMV-induced retinal disease in the SCID mouse measured by electroretinography, a non-invasive technique.
    Garneau M; Bolger GT; Bousquet C; Kibler P; Tremblay F; Cordingley MG
    Antiviral Res; 2003 Aug; 59(3):193-200. PubMed ID: 12927309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report.
    Rahhal FM; Arevalo JF; Chavez de la Paz E; Munguia D; Azen SP; Freeman WR
    Ann Intern Med; 1996 Jul; 125(2):98-103. PubMed ID: 8678386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Kirsch LS; Arevalo JF; De Clercq E; Chavez de la Paz E; Munguia D; Garcia R; Freeman WR
    Am J Ophthalmol; 1995 Apr; 119(4):466-76. PubMed ID: 7709971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.
    Stals FS; Zeytinoglu A; Havenith M; de Clercq E; Bruggeman CA
    Antimicrob Agents Chemother; 1993 Feb; 37(2):218-23. PubMed ID: 8383939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
    Smee DF; Bailey KW; Sidwell RW
    Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects.
    Taskintuna I; Banker AS; Rao NA; Wiley CA; Flores-Aguilar M; Munguia D; Bergeron-Lynn G; De Clercq E; Keefe K; Freeman WR
    Exp Eye Res; 1997 May; 64(5):795-806. PubMed ID: 9245910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine against human cytomegalovirus when administered as single-bolus dose and continuous infusion in in vitro cell culture perfusion system.
    Moore MR; Hamzeh FM; Lee FE; Lietman PS
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2404-8. PubMed ID: 7840578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
    Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH
    J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.